191 related articles for article (PubMed ID: 37237469)
1. Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases.
Johannwerner L; Werner EM; Blanck O; Janssen S; Cremers F; Yu NY; Rades D
Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237469
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases.
Johannwerner L; Werner EM; Janssen S; Yu NY; Rades D
Anticancer Res; 2023 Jun; 43(6):2757-2762. PubMed ID: 37247897
[TBL] [Abstract][Full Text] [Related]
3. FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.
Putz F; Weissmann T; Oft D; Schmidt MA; Roesch J; Siavooshhaghighi H; Filimonova I; Schmitter C; Mengling V; Bert C; Frey B; Lettmaier S; Distel LV; Semrau S; Fietkau R
Front Oncol; 2020; 10():559193. PubMed ID: 33102223
[No Abstract] [Full Text] [Related]
4. Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.
Palmer JD; Perlow HK; Matsui JK; Ho C; Prasad RN; Liu K; Upadhyay R; Klamer B; Wang J; Damante M; Ghose J; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Lonser R; Hardesty D; Prevedello D; Prabhu R; Elder JB; Raval RR
J Neurooncol; 2022 Sep; 159(2):389-395. PubMed ID: 35751740
[TBL] [Abstract][Full Text] [Related]
5. Reirradiation of metastases of the central nervous system: part 1-brain metastasis.
Rades D; Simone CB; Wong HCY; Chow E; Lee SF; Johnstone PAS
Ann Palliat Med; 2024 Mar; ():. PubMed ID: 38509654
[TBL] [Abstract][Full Text] [Related]
6. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
7. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
8. Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed Brain Metastasis.
Matsuda R; Morimoto T; Tamamoto T; Inooka N; Ochi T; Miyasaka T; Hontsu S; Yamaki K; Miura S; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Motoyama Y; Park YS; Hasegawa M; Nakase H
Curr Oncol; 2021 Dec; 28(6):5255-5265. PubMed ID: 34940078
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
[TBL] [Abstract][Full Text] [Related]
10. Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases.
Perlow HK; Ho C; Matsui JK; Prasad RN; Klamer BG; Wang J; Damante M; Upadhyay R; Thomas E; Blakaj DM; Beyer S; Lonser R; Hardesty D; Raval RR; Prabhu R; Elder JB; Palmer JD
Clin Transl Radiat Oncol; 2023 Jan; 38():117-122. PubMed ID: 36420099
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Rogers S; Baumert B; Blanck O; Böhmer D; Boström J; Engenhart-Cabillic R; Ermis E; Exner S; Guckenberger M; Habermehl D; Hemmatazad H; Henke G; Lohaus F; Lux S; Mai S; Minasch D; Rezazadeh A; Steffal C; Temming S; Wittig A; Zweifel C; Riesterer O; Combs SE
Strahlenther Onkol; 2022 Oct; 198(10):919-925. PubMed ID: 36006436
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
13. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
14. Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis.
Upadhyay R; Ayan AS; Jain S; Klamer BG; Perlow HK; Zoller W; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Raval RR; Palmer JD
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):275-284. PubMed ID: 37574170
[TBL] [Abstract][Full Text] [Related]
15. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
20. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
